Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes: A 24-week, randomized, double-blind, placebo-controlled trial

OBJECTIVE: To investigate the efficacy and tolerability of empagliflozin as add-on to metformin and sulfonylurea in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: Patients inadequately controlled on metformin and sulfonylurea (HbA(1c) ≥7 to ≤10%) were randomized and treated with once-da...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Häring, Hans-Ulrich, Merker, Ludwig, Seewaldt-Becker, Elke, Weimer, Marc, Meinicke, Thomas, Woerle, Hans J., Broedl, Uli C.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Diabetes Association 2013
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3816918/
https://ncbi.nlm.nih.gov/pubmed/23963895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2673
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky